Supernus Pharmaceuticals, Inc. (SUPN)
45.82
+0.40
(+0.88%)
USD |
NASDAQ |
Dec 10, 15:09
Supernus Pharmaceuticals Market Cap: 2.627B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 26.00B |
| BridgeBio Pharma, Inc. | 14.06B |
| CorMedix, Inc. | 879.29M |
| Assembly Biosciences, Inc. | 568.47M |
| Viking Therapeutics, Inc. | 4.237B |
Market Cap Related Metrics
| PS Ratio | 3.790 |
| Price to Book Value | 2.503 |
| Price to Free Cash Flow | 36.51 |
| Price | 45.82 |
| Earnings Yield | -0.74% |